Liver transplant and Dermatitis - atopic

Summary:

Dermatitis - atopic is found among people with Liver transplant, especially for people who are male, 2-9 old.

The study analyzes which people have Dermatitis - atopic with Liver transplant. It is created by eHealthMe based on reports of 17 people who have Liver transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Liver transplant?

Liver transplant is found to be associated with 330 drugs and 630 conditions by eHealthMe. Check the latest studies of Liver transplant.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,958 drugs and 1,976 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

17 people who have Liver Transplant and Dermatitis - Atopic are studied.

Would you have Dermatitis - atopic when you have Liver transplant?

Gender of people who have Liver Transplant and experienced Dermatitis - Atopic *:

female: 47.06 %
male: 52.94 %

Age of people who have Liver Transplant and experienced Dermatitis - Atopic *:

Common co-existing conditions for these people *:

High Blood Pressure: 1 person, 5.88%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 5.88%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Food Allergy: 4 people, 23.53%
Eosinophilic Esophagitis (Eosinophilic esophagitis (EoE) is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell): 3 people, 17.65%
Liver Transplant Rejection (failure of liver transplant): 3 people, 17.65%
Gastroenteritis Eosinophilic (white blood cell deposits in tissue of stomach or intestine with infection): 3 people, 17.65%
Asthma: 3 people, 17.65%
Blood Immunoglobulin E Increased: 2 people, 11.76%
Cytomegalovirus Infection: 2 people, 11.76%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 11.76%
Diarrhea: 2 people, 11.76%
Drug Resistance (reduction in effectiveness of a drug): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Liver transplant (19,223 reports)
Dermatitis - atopic (61,311 reports)

All the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,958 drugs)

All the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,976 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Dermatitis - atopic and Liver transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.